Professor & Director Precision Health.🇮🇪🇬🇧🇿🇲🇪🇺 🧬biomarker & Rx discovery. Biotech. ⬆️ DIE in research. LFC, volleyball, Irish Rugby. Views my own. YNWA
@ibdseb@IBD_MB I’m always concerned by guidelines and I understand they serve a purpose. In IBD probably more than other fields “Guidelines should be the floor not the ceiling.”
We’re proud to announce that the 100th participant has been enrolled in the OmiCrohn study! And we’re already moving forward: with 104 participants enrolled, we’ve reached 27.5% of our target of 378 participants!
https://t.co/Qz5JfWOF3U
#OmiCrohn#METHYLOMIC#CrohnsDisease#IBD
I can’t think of anyone more deserving of this Rising Star Award than Nuru
Beyond his extraordinary scientific contributions, he is genuinely one of the most generous people in IBD. He constantly creates opportunities, gives visibility, and makes space for those of us who may not have the same support or opportunities
He is leading an unprecedented shift in how clinical trials are designed, bringing a level of passion, vision, and endless energy that is truly inspiring
I couldn’t be prouder of him, not only for what he is achieving, but for the way he brings others along with him. So well deserved!
Time to reflect and celebrate #VERDICT
With those who were instrumental in conceiving (@PeyrinBiroulet ) and delivering (@vipuljairath )
Fitting tribute to #ProfFeagan
Thanks to all the patients who participated in this practice changing study
Every IBD drug has a person behind it.
A Swedish professor who designed sulfasalazine for rheumatism.
A chemist who couldn't get a research post, largely because she was a woman, and went on to win a Nobel Prize.
A virologist who left Czechoslovakia for a weekend in Vienna and never went back.
A young Canadian who made the antibody that became vedolizumab, and died fifteen years before it was licensed.
A century of IBD drugs, part 1: the people behind the discoveries. New on Atomic IBD.
Who did I miss?
An engaging start in Nashville!🤠🤠
Excellent discussion on #TL1A biology, emerging inhibitors, and what they may mean for the future of #IBD care.
A huge thank you to Drs. Bruce Sands, Maia Kayal, Millie Long, and Dermot McGovern for sharing their expertise and perspectives on the evolving landscape of IBD care! @bruce_sands1, @MaiaKayalMD, @MLongMD, @doc_ibd & @VindicoMedEd
I don't know why this hasn't received more publicity, but this fifty-foot sculpture was unveiled recently in South Dakota.
It's called 'Dignity' and was done by artist Dale Lamphere to honor the women of the Sioux Nation.
Thank you for liking my post!
During this CE Dinner in Nashville, Drs. @bruce_sands1, @MaiaKayalMD, @mlongMD and @doc_ibd will review the role of the TL1A pathway in IBD pathogenesis, and explore how these agents may influence future treatment decisions >> https://t.co/932xZyOEy1
@AmCollegeGastro#ACG2026
Going to ACG? Come and have dinner with me, @bruce_sands1, @MLongMD and @doc_ibd Friday 10/9 as we discuss all things TL1A 🧬 Good food, great company, one very hot target 🎯